IRIS
COLOMBO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.185
EU - Europa 3.717
NA - Nord America 2.706
SA - Sud America 1.220
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 11.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.589
RU - Federazione Russa 2.390
SG - Singapore 1.726
CN - Cina 1.158
BR - Brasile 995
HK - Hong Kong 528
SE - Svezia 526
VN - Vietnam 431
FR - Francia 211
IT - Italia 207
DE - Germania 113
AR - Argentina 87
GB - Regno Unito 85
IN - India 66
CA - Canada 49
EC - Ecuador 44
MX - Messico 44
BD - Bangladesh 39
ID - Indonesia 35
FI - Finlandia 31
TR - Turchia 28
IQ - Iraq 27
IE - Irlanda 26
JP - Giappone 26
CO - Colombia 25
PY - Paraguay 25
PL - Polonia 23
ZA - Sudafrica 21
AT - Austria 20
NL - Olanda 19
UZ - Uzbekistan 19
ES - Italia 17
LT - Lituania 14
PE - Perù 14
PK - Pakistan 14
UA - Ucraina 13
CL - Cile 11
MA - Marocco 11
TN - Tunisia 11
IR - Iran 10
SA - Arabia Saudita 9
EG - Egitto 8
VE - Venezuela 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
JO - Giordania 7
PH - Filippine 7
UY - Uruguay 7
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
ET - Etiopia 5
IL - Israele 5
NP - Nepal 5
OM - Oman 5
EU - Europa 4
KW - Kuwait 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
AM - Armenia 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
HN - Honduras 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
SC - Seychelles 2
SN - Senegal 2
SR - Suriname 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
Totale 11.906
Salva come PNG Salva come JPEG
Città #
Dallas 707
Singapore 665
Moscow 554
Hong Kong 521
Ashburn 306
San Jose 296
Shanghai 288
Hefei 212
Princeton 192
Lawrence 191
Lauterbourg 181
Ho Chi Minh City 152
Hanoi 94
New York 91
Beijing 90
São Paulo 84
Milan 63
Los Angeles 50
Da Nang 31
Orem 31
Santa Clara 30
Boardman 29
Brooklyn 27
Brasília 26
Nuremberg 26
Dublin 25
Belo Horizonte 24
Chennai 24
Haiphong 24
Helsinki 24
Rio de Janeiro 23
Munich 20
Guangzhou 18
London 18
Tashkent 18
Warsaw 18
Houston 17
Montreal 16
Porto Alegre 16
Tokyo 16
Denver 15
Johannesburg 15
Mexico City 15
Quito 15
Salvador 15
Biên Hòa 14
Frankfurt am Main 14
Guayaquil 14
Rome 14
The Dalles 13
Brescia 12
Chicago 12
Council Bluffs 12
Curitiba 12
Manchester 12
Boston 11
Hangzhou 11
Mumbai 11
Phoenix 11
Bogotá 10
Sorocaba 10
Stockholm 10
Ankara 9
Campinas 9
Changsha 9
Fortaleza 9
Guarulhos 9
Lima 9
Poplar 9
São Bernardo do Campo 9
Atlanta 8
Buenos Aires 8
Dhaka 8
Hải Dương 8
Recife 8
Toronto 8
Uberlândia 8
Vienna 8
Amsterdam 7
Durham 7
Goiânia 7
Istanbul 7
São Gonçalo 7
Vancouver 7
Amman 6
Assago 6
Cabo Frio 6
Caxias do Sul 6
Erbil 6
Itaquaquecetuba 6
Jakarta 6
Marília 6
Montevideo 6
Ninh Bình 6
São Vicente 6
Thái Bình 6
Anápolis 5
Asunción 5
Baku 5
Calgary 5
Totale 5.786
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 223
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 139
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 138
[New therapeutic options for the treatment of tricuspid regurgitation] 135
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 128
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 124
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 110
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 108
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 103
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 103
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 102
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 101
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 99
Diabetes and mortality in patients with COVID-19: Are we missing the link? 98
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 97
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 96
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 94
A new tool for the forgotten valve: a score to predict the risk of surgery 94
[40 Years of coronary angioplasty: success comes from skills and determination!] 93
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 92
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 91
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 91
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 91
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 89
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 88
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 88
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 88
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 83
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 81
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 81
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 80
Advances in percutaneous interventional therapies: The tricuspid valve 79
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 77
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 76
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 73
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 72
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 72
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 70
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 70
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 70
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 68
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 67
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 67
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 67
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 66
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 66
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 66
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 65
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 65
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 65
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 65
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 64
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 63
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 63
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 62
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 62
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 61
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 60
Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future 60
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 60
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 59
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 59
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 58
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? 58
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 58
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 57
Subclinical Leaflet Thrombosis After Transcatheter Mitral Valve-in-Ring Implantation 57
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 57
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 57
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 57
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 57
Dual antiplatelet therapy after drug-eluting stents. How long to treat? 56
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 56
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 56
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 56
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 56
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 56
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 56
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 56
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 56
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 55
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 55
Outcomes in coronary stents trials - 1 year is not enough 54
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 54
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis 54
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 54
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 54
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 54
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 54
VASCULAR COMPLICATIONS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH BOTH EDWARDS SAPIEN AND MEDTRONIC COREVALVE(R) BIOPROSTHESIS USING TRANSFEMORAL APPROACH SUPPORTED BY THE CROSS-OVER TECHNIQUE 54
Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement 53
Current Risk of Contrast-Induced Acute Kidney Injury After Coronary Angiography and Intervention: A Reappraisal of the Literature 53
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort 53
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study 53
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 52
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 52
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 52
Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation 51
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media 51
Unanticipated pseudocoarctation highlights the importance of visualizing aortic arch anatomy before transfemoral transcatheter aortic valve implantation 51
Totale 7.370
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 1 1 1
2021/202299 5 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024444 19 32 53 59 37 50 13 41 5 10 21 104
2024/20252.582 386 23 16 59 63 209 361 186 452 293 257 277
2025/20267.858 503 786 919 1.288 581 188 680 491 2.147 275 0 0
Totale 12.208